Skip to main content

Table 3 Perioperative clinical outcomes

From: Impact of perioperative low-molecular-weight heparin therapy on clinical events of elderly patients with prior coronary stents implanted > 12 months undergoing non-cardiac surgery: a randomized, placebo-controlled trial

Variable

Bridging (N = 1242)

No bridging (N = 1234)

P value

Primary endpoints

 Myocardial injury, n (%)

39 (3.14)

64 (5.19)

0.011

 Acute myocardial infarction, n (%)

10 (0.81)

17 (1.38)

0.170

 Cardiac death, n (%)

3 (0.24)

5 (0.41)

0.473

 Stroke, n (%)

2 (0.16)

3 (0.24)

0.649

 Major bleeding, n (%)

18 (1.45)

15 (1.22)

0.612

 The combined primary endpoint

72 (5.79)

104 (8.42)

0.012

Secondary endpoints

 Death, n (%)

6 (0.48)

8 (0.65)

0.584

 Deep-vein thrombosis, n (%)

5 (0.40)

15 (1.21)

0.024

 Pulmonary embolism, n (%)

1 (0.08)

4 (0.32)

0.177

 Minor bleeding, n (%)

19 (1.53)

8 (0.65)

0.035

 The combined secondary endpoint, n (%)

31 (2.50)

35 (2.83)

0.620